FDA warns Novo Nordisk over unreported potential Ozempic side effects
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
Watch CBS News
The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy the drugs directly.
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
A one-month supply of Ozempic and Wegovy will now cost $499 out of pocket for Costco shoppers.
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a rule the Biden administration has proposed.
Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Semaglutide, the active ingredient in drugs like Wegovy and Ozempic, can help people lose weight — and a new study says it may also help people quit smoking.
Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized.
From the Ozempic "ripple effect" to health tech and more, experts share their predictions for 2024 wellness trends.
The FDA and drugmaker Novo Nordisk are working to identify thousands of counterfeit Ozempic drugs seized in an ongoing investigation.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
It is unclear if the counterfeit drugs, which many people seek for weight loss, caused the hospitalizations.
The warning about scams comes as sales have boomed for Ozempic, Wegovy and other drugs used for weight loss.
The FDA stopped short of saying the potentially life-threatening condition was caused by the drugs, which have become popular for weight loss.
While Ozempic's interaction with the reward centers in our brain could help explain this, Dr. Tamika Henry, founder of Unlimited Health Institute, says more studies are needed.
